Your browser is out-of-date.
Please, update your browser to view this website correctly.
Update my browser now
×
Courses
Research
Educational
GIUSEPPE ROI CENTER
FELLOWSHIP
PUBLICATIONS
PARTNERSHIPS
RESEARCH FIELDS
THE INSTITUTE
HISTORY
Contact us
*
Name
*
Surname
Job
*
Email
Phone
Fax
*
Address
*
Cap
*
City
*
Country
*
Request
'New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments. ' Theranostics. 2019 Jul 9;9(18):5332-5346. Protocollo n. 1578
I agree to the terms and privacy policy
